NCT02335359View on ClinicalTrials.gov

Tranexamic Acid in Major Vascular Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 4, 2015

Primary Completion Date

October 30, 2017

Study Completion Date

October 30, 2018

Conditions
Blood Loss, Surgical
Interventions
DRUG

tranexamic acid diluted in 100 ml of saline solution (loading dose)

DRUG

tranexamic acid undiluted (continous infusion)

DRUG

Placebo

Saline

Trial Locations (1)

20132

IRCCS San Raffaele Scientific Institute, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER

NCT02335359 - Tranexamic Acid in Major Vascular Surgery | Biotech Hunter | Biotech Hunter